Attovia Therapeutics Inc. logo

Attovia Therapeutics Inc.

ATTO | NASDAQ
Chart Builder DCF Calculator
$21.14
-$0.16 (-0.75%)
Sep 22, 2026, 10:51 AM ET · Market open
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q1 2025
Mar 30, 2025
PE Ratio
-23.55 -45.63 -54.75
PEG Ratio
3.77 n/a n/a
PS Ratio
2.22K n/a n/a
PB Ratio
8.87 6.36 n/a
P/FCF Ratio
-28.33 -45.79 -52.99
P/OCF Ratio
-28.62 -46.51 -59.71
OCF/S Ratio
-3.73K n/a n/a
Debt / Equity Ratio
0.04 0.04 n/a
Quick Ratio
9.39 13.94 n/a
Current Ratio
9.39 13.94 n/a
Asset Turnover
0 n/a n/a
Interest Coverage
n/a n/a n/a
Return on Equity
-18.34% -14.06% n/a
Return on Assets
-16.12% -12.77% n/a
Return on Invested Capital
-18.51% -14.43% n/a
Dividend Yield
n/a n/a n/a
Payout Ratio
n/a n/a n/a
FCF Payout Ratio
n/a n/a n/a
Gross Profit Margin
45.33% n/a n/a
Net Profit Margin
-4.6K% n/a n/a
Pretax Profit Margin
-4.6K% n/a n/a
Operating Profit Margin
-4.85K% n/a n/a
FCF Margin
-3.75K% n/a n/a
EBITDA Margin
-4.79K% n/a n/a

© 2026 bestshares.com. All rights reserved.